Interactions between E6, FAK, and GIT1 at paxillin LD4 are necessary for transformation by bovine papillomavirus 1 E6

Journal of Virology

Volumn 88, Issue 17, 2014, Pages 9927-9933

  Brimer, Nicole ^a   Wade, Ramon ^a,b   Vande Pol, Scott ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Novelmed   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; FOCAL ADHESION KINASE 1; GIT1 PROTEIN, MOUSE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; ONCOPROTEIN; PAXILLIN; PROTEIN E6, BOVINE PAPILLOMAVIRUS; PTK2 PROTEIN, MOUSE;

ANIMAL; BOVINE PAPILLOMAVIRUS TYPE 1; CELL CULTURE; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN ANALYSIS;

ANIMALS; BOVINE PAPILLOMAVIRUS 1; CELL CYCLE PROTEINS; CELLS, CULTURED; FOCAL ADHESION KINASE 1; GTPASE-ACTIVATING PROTEINS; MICE; ONCOGENE PROTEINS, VIRAL; PAXILLIN; PROTEIN INTERACTION MAPPING;

EID: 84921972565     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00552-14     Document Type: Article

References (41)

1. Tong X, Howley PM. 1997. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc. Natl. Acad. Sci. U. S. A. 94:4412-4417. http://dx.doi.org/10.1073/pnas.94.9.4412.
2. Vande Pol SB, Brown MC, Turner CE. 1998. Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene 16:43-52. http://dx.doi.org/10.1038/sj.onc.1201504.
3. Tong X, Boll W, Kirchhausen T, Howley PM. 1998. Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1. J. Virol. 72:476-482.
4. Brimer N, Lyons C, Wallberg AE, Vande Pol SB. 2012. Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation andNOTCHsignaling. Oncogene 31:4639-4646. http://dx.doi.org/10.1038/onc.2011.589.
5. Tan MJ, White EA, Sowa ME, Harper JW, Aster JC, Howley PM. 2012. Cutaneous beta-human papillomavirus E6 proteins bind Mastermindlike coactivators and repress Notch signaling. Proc. Natl. Acad. Sci. U. S. A. 109:E1473-E1480. http://dx.doi.org/10.1073/pnas.1205991109.
6. Zanier K, Charbonnier S, Sidi AO, McEwen AG, Ferrario MG, Poussin-Courmontagne P, Cura V, Brimer N, Babah KO, Ansari T, Muller I, Stote RH, Cavarelli J, Vande Pol S, Trave G. 2013. Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins. Science 339:694-698. http://dx.doi.org/10.1126/science.1229934.
7. Wade R, Brimer N, Vande Pol S. 2008. Transformation by bovine papillomavirus type 1 E6 requires paxillin. J. Virol. 82:5962-5966. http://dx.doi.org/10.1128/JVI.02747-07.
8. Huibregtse JM, Scheffner M, Howley PM. 1993. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell. Biol. 13: 4918-4927.
9. Chen JJ, Hong Y, Rustamzadeh E, Baleja JD, Androphy EJ. 1998. Identification of an alpha helical motif sufficient for association with papillomavirus E6. J. Biol. Chem. 273:13537-13544. http://dx.doi.org/10.1074/jbc.273.22.13537.
10. Brimer N, Lyons C, Vande Pol SB. 2007. Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein. Virology 358:303-310. http://dx.doi.org/10.1016/j.virol.2006.08.038.
11. White EA, Kramer RE, Tan MJ, Hayes SD, Harper JW, Howley PM. 2012. Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity. J. Virol. 86:13174-13186. http://dx.doi.org/10.1128/JVI.02172-12.
12. Hagel M, George EL, Kim A, Tamimi R, Opitz SL, Turner CE, Imamoto A, Thomas SM. 2002. The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol. Cell. Biol. 22:901-915. http://dx.doi.org/10.1128/MCB.22.3.901-915.2002.
13. Chen GC, Turano B, Ruest PJ, Hagel M, Settleman J, Thomas SM. 2005. Regulation of Rho and Rac signaling to the actin cytoskeleton by paxillin during Drosophila development. Mol. Cell. Biol. 25:979-987. http://dx.doi.org/10.1128/MCB.25.3.979-987.2005.
14. Deakin NO, Turner CE. 2008. Paxillin comes of age. J. Cell Sci. 121:2435-2444. http://dx.doi.org/10.1242/jcs.018044.
15. Mitra SK, Schlaepfer DD. 2006. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 18:516-523. http://dx.doi.org/10.1016/j.ceb.2006.08.011.
16. Shen Y, Schneider G, Cloutier JF, Veillette A, Schaller MD. 1998. Direct association of protein-tyrosine phosphatase PTP-PEST with paxillin. J. Biol. Chem. 273:6474-6481. http://dx.doi.org/10.1074/jbc.273.11.6474.
17. Turner CE, Brown MC, Perrotta JA, Riedy MC, Nikolopoulos SN, McDonald AR, Bagrodia S, Thomas S, Leventhal PS. 1999. Paxillin LD4 motif binds PAK and PIX through a novel 95-kD ankyrin repeat, ARFGAP protein: a role in cytoskeletal remodeling. J. Cell Biol. 145:851-863. http://dx.doi.org/10.1083/jcb.145.4.851.
18. Webb DJ, Brown CM, Horwitz AF. 2003. Illuminating adhesion complexes in migrating cells: moving toward a bright future. Curr. Opin. Cell Biol. 15:614-620. http://dx.doi.org/10.1016/S0955-0674(03)00105-4.
19. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF. 2004. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat. Cell Biol. 6:154-161. http://dx.doi.org/10.1038/ncb1094.
20. Hall A. 2012. Rho family GTPases. Biochem. Soc. Trans. 40:1378-1382. http://dx.doi.org/10.1042/BST20120103.
21. Wade R, Brimer N, Lyons C, Vande Pol S. 2011. Paxillin enables attachment-independent tyrosine phosphorylation of focal adhesion kinase and transformation by RAS. J. Biol. Chem. 286:37932-37944. http://dx.doi.org/10.1074/jbc.M111.294504.
22. Nikolopoulos SN, Turner CE. 2000. Actopaxin, a new focal adhesion protein that binds paxillin LD motifs and actin and regulates cell adhesion. J. Cell Biol. 151:1435-1448. http://dx.doi.org/10.1083/jcb.151.7.1435.
23. Nikolopoulos SN, Turner CE. 2001. Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions. J. Biol. Chem. 276:23499-23505. http://dx.doi.org/10.1074/jbc.M102163200.
24. Chua GL, Patra AT, Tan SM, Bhattacharjya S. 2013. NMR structure of integrin alpha4 cytosolic tail and its interactions with paxillin. PLoS One 8:e55184. http://dx.doi.org/10.1371/journal.pone.0055184.
25. Manetti ME, Geden S, Bott M, Sparrow N, Lambert S, Fernandez-Valle C. 2012. Stability of the tumor suppressor merlin depends on its ability to bind paxillin LD3 and associate with beta1 integrin and actin at the plasma membrane. Biol. Open 1:949-957. http://dx.doi.org/10.1242/bio.20122121.
26. Wade R, Vande Pol S. 2006. Minimal features of paxillin that are required for the tyrosine phosphorylation of focal adhesion kinase. Biochem. J. 393:565-573. http://dx.doi.org/10.1042/BJ20051241.
27. Tong X, Salgia R, Li JL, Griffin JD, Howley PM. 1997. The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase. J. Biol. Chem. 272:33373-33376. http://dx.doi.org/10.1074/jbc.272.52.33373.
28. Brown MC, Perotta JA, Turner CE. 1996. Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding. J. Cell. Biol. 135:1109-1123. http://dx.doi.org/10.1083/jcb.135.4.1109.
29. Cote JF, Turner CE, Tremblay ML. 1999. Intact LIM 3 and LIM 4 domains of paxillin are required for the association to a novel polyproline region (Pro 2) of protein-tyrosine phosphatase-PEST. J. Biol. Chem. 274: 20550-20560. http://dx.doi.org/10.1074/jbc.274.29.20550.
30. Shibanuma M, Mashimo J, Kuroki T, Nose K. 1994. Characterization of the TGF beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence. J. Biol. Chem. 269:26767-26774.
31. Shibanuma M, Kim-Kaneyama JR, Sato S, Nose K. 2004. A LIM protein, Hic-5, functions as a potential coactivator for Sp1. J. Cell. Biochem. 91: 633-645. http://dx.doi.org/10.1002/jcb.10754.
32. Heitzer MD, DeFranco DB. 2006. Hic-5/ARA55, a LIM domaincontaining nuclear receptor coactivator expressed in prostate stromal cells. Cancer Res. 66:7326-7333. http://dx.doi.org/10.1158/0008-5472.CAN-05-2379.
33. Wang H, Song K, Krebs TL, Yang J, Danielpour D. 2008. Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55. Oncogene 27:6791-6805. http://dx.doi.org/10.1038/onc.2008.291.
34. Shibanuma M, Mochizuki E, Maniwa R, Mashimo J, Nishiya N, Imai S, Takano T, Oshimura M, Nose K. 1997. Induction of senescence-like phenotypes by forced expression of hic-5, which encodes a novel LIM motif protein, in immortalized human fibroblasts. Mol. Cell. Biol. 17: 1224-1235.
35. Kim-Kaneyama JR, Takeda N, Sasai A, Miyazaki A, Sata M, Hirabayashi T, Shibanuma M, Yamada G, Nose K. 2011. Hic-5 deficiency enhances mechanosensitive apoptosis and modulates vascular remodeling. J. Mol. Cell. Cardiol. 50:77-86. http://dx.doi.org/10.1016/j.yjmcc.2010.09.024.
36. Kim-Kaneyama JR, Miyauchi A, Lei XF, Arita S, Mino T, Takeda N, Kou K, Eto K, Yoshida T, Miyazaki T, Shioda S, Miyazaki A. 2012. Identification of Hic-5 as a novel regulatory factor for integrin alphaIIbbeta3 activation and platelet aggregation in mice. J. Thromb. Haemost. 10:1867-1874. http://dx.doi.org/10.1111/j.1538-7836.2012.04856.x.
37. Bohl J, Das K, Dasgupta B, Vande Pol SB. 2000. Competitive binding to a charged leucine motif represses transformation by a papillomavirus E6 oncoprotein. Virology 271:163-170. http://dx.doi.org/10.1006/viro.2000.0316.
38. Elroy-Stein O, Fuerst TR, Moss B. 1989. Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5= sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc. Natl. Acad. Sci. U. S. A. 86:6126-6130. http://dx.doi.org/10.1073/pnas.86.16.6126.
39. Tomaic V, Pim D, Banks L. 2009. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent. Virology 393:7-10. http://dx.doi.org/10.1016/j.virol.2009.07.029.
40. Ansari T, Brimer N, Vande Pol SB. 2012. Peptide interactions stabilize and restructure human papillomavirus type 16 E6 to interact with p53. J. Virol. 86:11386-11391. http://dx.doi.org/10.1128/JVI.01236-12.
41. Wade R, Bohl J, Vande Pol S. 2002. Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase. Oncogene 21:96-107. http://dx.doi.org/10.1038/sj.onc.1205013.